Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Large cardiovascular outcome trials, including LEADER (liraglutide), SUSTAIN-6 (semaglutide), and REWIND (dulaglutide), have demonstrated cardiovascular risk reduction with GLP-1 receptor agonists
Card et al., 2018
2,3 GLP-1RAs influence the hypothalamic-pituitary-ovarian axis, enhancing gonadotropin secretion and improving ovarian function
(7) Studies without a separate control group
Serious and Rare Risks Associated with Mounjaro Most people have good tolerance to Mounjaro, although some end up with more serious health problems
US$ 27.09
US$ 20.17
US$ 20.77
US$ 24.71
US$ 25.18
